🇺🇸 FDA
Patent

US 9402889

Live, oral vaccine for protection against Shigella dysenteriae serotype 1

granted A61KA61K2039/522A61K2039/523

Quick answer

US patent 9402889 (Live, oral vaccine for protection against Shigella dysenteriae serotype 1) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/522, A61K2039/523, A61K39/0283, A61K48/00